37.71
-1.715(-4.35%)
Currency In USD
| Previous Close | 39.42 |
| Open | 39.08 |
| Day High | 39.27 |
| Day Low | 37.64 |
| 52-Week High | 91.83 |
| 52-Week Low | 26.7 |
| Volume | 312,966 |
| Average Volume | 437,574 |
| Market Cap | 793.54M |
| PE | -3.04 |
| EPS | -12.4 |
| Moving Average 50 Days | 49.11 |
| Moving Average 200 Days | 53.06 |
| Change | -1.72 |
If you invested $1000 in Praxis Precision Medicines, Inc. (PRAX) since IPO date, it would be worth $90.42 as of September 13, 2025 at a share price of $37.705. Whereas If you bought $1000 worth of Praxis Precision Medicines, Inc. (PRAX) shares 3 years ago, it would be worth $927.55 as of September 13, 2025 at a share price of $37.705.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Praxis Precision Medicines to Participate in September Investor Conferences
GlobeNewswire Inc.
Sep 04, 2025 8:01 PM GMT
BOSTON, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders
Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline
GlobeNewswire Inc.
Aug 25, 2025 8:01 PM GMT
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders, today announced its participation in t
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
GlobeNewswire Inc.
Aug 05, 2025 12:24 AM GMT
BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characte